Next Article in Journal
Combination Therapy with Rituximab, Tofacitinib and Pirfenidone in a Patient with Rapid Progressive Interstitial Lung Disease (RP-ILD) Due to MDA5 Antibody-Associated Dermatomyositis: A Case Report
Previous Article in Journal
Factors Associated with ICU Admission in Patients with COVID-19: The GOL2DS Score
 
 
Article

Article Versions Notes

Medicina 2021, 57(12), 1357; https://doi.org/10.3390/medicina57121357
Action Date Notes Link
article xml file uploaded 13 December 2021 09:39 CET Original file -
article xml uploaded. 13 December 2021 09:39 CET Update https://www.mdpi.com/1648-9144/57/12/1357/xml
article pdf uploaded. 13 December 2021 09:39 CET Version of Record https://www.mdpi.com/1648-9144/57/12/1357/pdf
article html file updated 13 December 2021 09:40 CET Original file -
article html file updated 30 July 2022 21:55 CEST Update https://www.mdpi.com/1648-9144/57/12/1357/html
Back to TopTop